vs

Side-by-side financial comparison of JBG SMITH Properties (JBGS) and U S PHYSICAL THERAPY INC (USPH). Click either name above to swap in a different company.

U S PHYSICAL THERAPY INC is the larger business by last-quarter revenue ($202.7M vs $127.6M, roughly 1.6× JBG SMITH Properties). U S PHYSICAL THERAPY INC runs the higher net margin — 2.0% vs -35.7%, a 37.8% gap on every dollar of revenue. On growth, U S PHYSICAL THERAPY INC posted the faster year-over-year revenue change (12.3% vs -2.5%). Over the past eight quarters, U S PHYSICAL THERAPY INC's revenue compounded faster (14.1% CAGR vs -6.3%).

JBG SMITH Properties is a publicly traded real estate investment trust based in Bethesda, Maryland.

U.S. Physical Therapy Inc. operates hundreds of outpatient physical therapy clinics across the U.S. It offers rehabilitative care for patients recovering from injuries, surgeries, chronic pain and mobility impairments, plus specialized services including sports medicine and pediatric rehabilitation.

JBGS vs USPH — Head-to-Head

Bigger by revenue
USPH
USPH
1.6× larger
USPH
$202.7M
$127.6M
JBGS
Growing faster (revenue YoY)
USPH
USPH
+14.8% gap
USPH
12.3%
-2.5%
JBGS
Higher net margin
USPH
USPH
37.8% more per $
USPH
2.0%
-35.7%
JBGS
Faster 2-yr revenue CAGR
USPH
USPH
Annualised
USPH
14.1%
-6.3%
JBGS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
JBGS
JBGS
USPH
USPH
Revenue
$127.6M
$202.7M
Net Profit
$-45.5M
$4.2M
Gross Margin
19.8%
Operating Margin
-47.5%
8.3%
Net Margin
-35.7%
2.0%
Revenue YoY
-2.5%
12.3%
Net Profit YoY
24.0%
-55.1%
EPS (diluted)
$-0.76
$-0.44

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
JBGS
JBGS
USPH
USPH
Q4 25
$127.6M
$202.7M
Q3 25
$123.9M
$197.1M
Q2 25
$126.5M
$197.3M
Q1 25
$120.7M
$183.8M
Q4 24
$130.8M
$180.4M
Q3 24
$136.0M
$168.0M
Q2 24
$135.3M
$167.2M
Q1 24
$145.2M
$155.7M
Net Profit
JBGS
JBGS
USPH
USPH
Q4 25
$-45.5M
$4.2M
Q3 25
$-28.6M
$13.1M
Q2 25
$-19.2M
$12.4M
Q1 25
$-45.7M
$9.9M
Q4 24
$-59.9M
$9.2M
Q3 24
$-27.0M
$6.6M
Q2 24
$-24.4M
$7.5M
Q1 24
$-32.3M
$8.0M
Gross Margin
JBGS
JBGS
USPH
USPH
Q4 25
19.8%
Q3 25
18.7%
Q2 25
21.1%
Q1 25
16.9%
Q4 24
18.0%
Q3 24
17.3%
Q2 24
20.3%
Q1 24
18.2%
Operating Margin
JBGS
JBGS
USPH
USPH
Q4 25
-47.5%
8.3%
Q3 25
-27.5%
12.8%
Q2 25
-18.4%
12.6%
Q1 25
-44.7%
10.7%
Q4 24
-53.6%
10.9%
Q3 24
-22.4%
7.6%
Q2 24
-24.3%
9.3%
Q1 24
-30.1%
9.6%
Net Margin
JBGS
JBGS
USPH
USPH
Q4 25
-35.7%
2.0%
Q3 25
-23.1%
6.7%
Q2 25
-15.2%
6.3%
Q1 25
-37.9%
5.4%
Q4 24
-45.8%
5.1%
Q3 24
-19.8%
3.9%
Q2 24
-18.0%
4.5%
Q1 24
-22.2%
5.2%
EPS (diluted)
JBGS
JBGS
USPH
USPH
Q4 25
$-0.76
$-0.44
Q3 25
$-0.48
$0.48
Q2 25
$-0.29
$0.58
Q1 25
$-0.56
$0.80
Q4 24
$-0.70
$0.52
Q3 24
$-0.32
$0.39
Q2 24
$-0.27
$0.47
Q1 24
$-0.36
$0.46

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
JBGS
JBGS
USPH
USPH
Cash + ST InvestmentsLiquidity on hand
$75.3M
$35.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.2B
$476.4M
Total Assets
$4.4B
$1.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
JBGS
JBGS
USPH
USPH
Q4 25
$75.3M
$35.6M
Q3 25
$64.4M
$31.1M
Q2 25
$61.4M
$34.1M
Q1 25
$81.3M
$39.2M
Q4 24
$145.8M
$41.4M
Q3 24
$137.0M
$117.0M
Q2 24
$163.5M
$112.9M
Q1 24
$220.5M
$132.3M
Stockholders' Equity
JBGS
JBGS
USPH
USPH
Q4 25
$1.2B
$476.4M
Q3 25
$1.2B
$503.6M
Q2 25
$1.3B
$500.8M
Q1 25
$1.6B
$497.3M
Q4 24
$1.8B
$488.9M
Q3 24
$1.9B
$482.8M
Q2 24
$2.0B
$484.6M
Q1 24
$2.1B
$479.8M
Total Assets
JBGS
JBGS
USPH
USPH
Q4 25
$4.4B
$1.2B
Q3 25
$4.4B
$1.2B
Q2 25
$4.5B
$1.2B
Q1 25
$4.7B
$1.2B
Q4 24
$5.0B
$1.2B
Q3 24
$5.2B
$1.0B
Q2 24
$5.3B
$1.0B
Q1 24
$5.4B
$1.0B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
JBGS
JBGS
USPH
USPH
Operating Cash FlowLast quarter
$73.3M
$24.9M
Free Cash FlowOCF − Capex
$21.0M
FCF MarginFCF / Revenue
10.4%
Capex IntensityCapex / Revenue
1.9%
Cash ConversionOCF / Net Profit
6.00×
TTM Free Cash FlowTrailing 4 quarters
$61.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
JBGS
JBGS
USPH
USPH
Q4 25
$73.3M
$24.9M
Q3 25
$8.9M
$19.9M
Q2 25
$18.8M
$34.9M
Q1 25
$12.9M
$-4.7M
Q4 24
$129.4M
$19.4M
Q3 24
$26.4M
$22.1M
Q2 24
$23.8M
$29.0M
Q1 24
$37.0M
$4.4M
Free Cash Flow
JBGS
JBGS
USPH
USPH
Q4 25
$21.0M
Q3 25
$15.6M
Q2 25
$31.6M
Q1 25
$-7.3M
Q4 24
$16.9M
Q3 24
$19.6M
Q2 24
$26.7M
Q1 24
$2.6M
FCF Margin
JBGS
JBGS
USPH
USPH
Q4 25
10.4%
Q3 25
7.9%
Q2 25
16.0%
Q1 25
-3.9%
Q4 24
9.4%
Q3 24
11.7%
Q2 24
15.9%
Q1 24
1.7%
Capex Intensity
JBGS
JBGS
USPH
USPH
Q4 25
1.9%
Q3 25
2.2%
Q2 25
1.6%
Q1 25
1.4%
Q4 24
1.4%
Q3 24
1.5%
Q2 24
1.4%
Q1 24
1.2%
Cash Conversion
JBGS
JBGS
USPH
USPH
Q4 25
6.00×
Q3 25
1.52×
Q2 25
2.81×
Q1 25
-0.47×
Q4 24
2.10×
Q3 24
3.34×
Q2 24
3.86×
Q1 24
0.55×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

JBGS
JBGS

Segment breakdown not available.

USPH
USPH

Net Patient Revenues$169.7M84%
Industrial Injury Prevention Services Revenues$28.9M14%
Management Contract Revenues$2.3M1%

Related Comparisons